Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis

Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety

(2020) Simona Lattanzi et al.   CNS DRUGS

Cenobamate for focal seizures — a game changer?

(2020) Jacqueline A. French   Nature Reviews Neurology

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial

(2020) David G. Vossler   Epilepsy Currents

Drug treatments in patients with cardiac diseases and epilepsy

(2020) Gaetano Zaccara et al.   ACTA NEUROLOGICA SCANDINAVICA

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

(2020) Michael R. Sperling et al.   EPILEPSIA

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures

(2020) Steve S. Chung et al.   NEUROLOGY

Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate

(2020) Ramesh Sharma et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety

(2019) Simona Lattanzi et al.   DRUGS

Comorbidity between epilepsy and cardiac arrhythmias: Implication for treatment

(2019) Gaetano Zaccara et al.   EPILEPSY & BEHAVIOR

Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons

(2019) Michiko Nakamura et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

(2019) Gregory L Krauss et al.   LANCET NEUROLOGY

Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   CEREBROVASCULAR DISEASES

Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs

(2018) Zhibin Chen et al.   JAMA Neurology

Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis

(2018) Simona Lattanzi et al.   ACTA NEUROLOGICA SCANDINAVICA

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   CNS DRUGS

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis

(2018) Simona Lattanzi et al.   DRUGS

Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System

(2018) Eric P. Borrelli et al.   EPILEPSIA

The impact of seizures on epilepsy outcomes: A national, community-based survey

(2017) Colin B. Josephson et al.   EPILEPSIA

Efficacy and safety of perampanel in Parkinson’s disease. A systematic review with meta-analysis

(2017) Simona Lattanzi et al.   JOURNAL OF NEUROLOGY

Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis

(2017) Simona Lattanzi et al.   JOURNAL OF NEUROLOGY

Lacosamide monotherapy for partial onset seizures

(2015) Simona Lattanzi et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

The consequences of refractory epilepsy and its treatment

(2014) Kenneth D. Laxer et al.   EPILEPSY & BEHAVIOR

Seizure course during pregnancy in catamenial epilepsy

(2014) C. Cagnetti et al.   NEUROLOGY

Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)

(2012) Meir Bialer et al.   EPILEPSY RESEARCH

Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta-analysis

(2011) João Costa et al.   EPILEPSIA

Combined analysis of risk factors for SUDEP

(2011) Dale C. Hesdorffer et al.   EPILEPSIA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE